The Global PARP Inhibitor Biomarkers Market is estimated to be valued at US$ 907.1 million in 2023 and is expected to exhibit a CAGR of 24.9% over the forecast period of 2023-2030, according to a new report published by Coherent Market Insights.

Market Overview:
The PARP Inhibitor Biomarkers Market refers to the market for markers or indicators that can be used to predict the response of cancer patients to PARP inhibitor therapy. PARP ... Read more

PARP inhibitor biomarkers are essential diagnostic tools for cancer treatment and identifying response rates to PARP inhibitor therapies. PARP inhibitors are increasingly used for the treatment of metastatic cancers with BRCA mutations. These inhibitors are primarily used for treating cancers like ovarian, breast, and prostate cancers. Rising cancer prevalence worldwide drives the adoption of precision medicine approaches like PARP inhibitors to gain improved treatment outcomes. PARP ... Read more